Trevi Therapeutics
TRVI
#4991
Rank
A$2.53 B
Marketcap
A$19.74
Share price
-7.06%
Change (1 day)
369.52%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2025 (TTM): -A$71.52 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$71.84 Million a decrease over its 2023 earnings that were of -A$43.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$71.52 Million-0.45%
2024 -A$71.84 Million67%
2023 -A$43.02 Million2.43%
2022 -A$42 Million-14.45%
2021 -A$49.09 Million1.36%
2020 -A$48.44 Million23.64%
2019 -A$39.18 Million27.54%
2018 -A$30.72 Million